Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study
Lixue Huang(Capital Medical University), Bin Cao(Shandong Provincial Hospital), Dan Cui(Dalian Medical University), Li Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiang Ren(Air Force Medical University), Hui Zhang(Binzhou University), Yimin Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianwei Wang(Chongqing Medical University), Xia Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Xinming Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoying Gu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xueyang Zhang(Tsinghua University), Yeming Wang(Academy of Medical Sciences), Jingchuan Zhong(Chinese Academy of Medical Sciences & Peking Union Medical College), Lianhan Shang(Chinese Academy of Medical Sciences & Peking Union Medical College), Min Liu(China-Japan Friendship Hospital)
Cited by 609
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k